Dopamine D2/D3 and serotonin 5-HT1A receptor drugs for Bipolar Disorder
2 tracked Dopamine D2/D3 and serotonin 5-HT1A receptor drugs in the Bipolar Disorder race. The class explanation lives on the Dopamine D2/D3 and serotonin 5-HT1A receptor page; the full indication pipeline across every mechanism is on the Bipolar Disorder page.
2 approved / phase 4